Patients could benefit from an immunotherapy jab for over a dozen different cancers, which can be given in just 60 seconds. The NHS is rolling out an injectable form of pembrolizumab (Keytruda) which can slash the time the treatment takes by up to 90%. The jab can be used to treat 14 different cancer types, including lung, breast, head and neck, and cervical, and works by triggering immune cells to recognise and kill cancer cells.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
Create a network to share documents, knowledge and best practice with your colleagues. Set up a network to keep in touch with other people in your organisation or with shared interest groups across organisational boundaries.
Networks can be open to all or available only to a closed group defined by the administrator.
Join or create a network here.
